Immune System Key Ltd
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML (NCT04365179) | Immune System Key Ltd | 2020-06-18 |
| A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS (NCT03059615) | Immune System Key Ltd | 2018-10-25 |
| Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer (NCT03634150) | Immune System Key Ltd | 2018-09-06 |
Track Immune System Key Ltd automatically
Every clearance here is in the API, with alerts when new ones post.